Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis
This meta-analysis synthesized current evidence from 10 trials to evaluate the association between steroid therapy and osteonecrosis incidence in patients with severe acute respiratory syndrome (SARS). Our results suggest that higher cumulative doses and longer treatment durations of steroids are more likely to lead to the development of osteonecrosis in SARS patients.
The link between steroid treatment and the risk of osteonecrosis in SARS patients remains unknown. The present meta-analysis aimed to examine the dose-response association between steroid therapy and osteonecrosis incidence in SARS patients. The sex differences in the development of steroid-induced osteonecrosis were also examined.
We searched PubMed, Web of Science, CNKI, and WANFANG for studies that involved steroid therapy and reported osteonecrosis data in SARS patients. Two authors independently extracted the data from the individual studies, and the rate ratio (RR) of osteonecrosis was calculated using random-effect models.
Ten studies with 1137 recovered SARS patients met the inclusion criteria. Close relationships between osteonecrosis incidence and both the cumulative dose and treatment duration of steroids were observed. The summary RR of osteonecrosis was 1.57 (95% confidence interval (CI) 1.30–1.89, p < 0.001) per 5.0 g increase in the cumulative dose of steroids and was 1.29 (95% CI 1.09–1.53, p = 0.003) for each 10-day increment of increase in treatment duration. The relationship was non-linear (p non-linear < 0.001 and p non-linear = 0.022). There were no significant differences in the risk of developing osteonecrosis between the male and female patients (RR 0.01, 95% CI −0.03 to 0.06, p = 0.582).
SARS patients who received higher cumulative doses and longer treatment durations of steroids were more likely to develop osteonecrosis, and there were no sex differences in this dose-dependent side effect. Our findings suggest that it is important to reduce osteonecrosis risk by modifying the cumulative dose and the treatment duration of steroids in SARS patients.
KeywordsDose-response Osteonecrosis SARS Sex difference Steroid therapy
This work was supported in part by the Zhejiang Provincial Natural Science Foundation of China under Grant (No. LY14H070001).
Compliance with ethical standards
Conflicts of interest
- 7.Chan-Yeung M, Ooi GC, Hui DS, Ho PL, Tsang KW (2003) Severe acute respiratory syndrome. The International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 7:1117–1130Google Scholar
- 9.Guo KJ, Zhao FC, Guo Y, Li FL, Zhu L, Zheng W (2014) The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: a retrospective study. The Bone Joint J 96-B:259–262CrossRefPubMedGoogle Scholar
- 10.Wu LH, Gao C, Wang GZ, Yang L, Hou XM, Ge H, Xia CQ, Qi M (2006) Clinical study on the relate marker of blood coagulation in the patients with avascular necrosis of the femoral head after treatment of severe acute respiratory syndrome with methylprednisolone. Chinese J Nautical Med Hyperbaric Med 13:39–41Google Scholar
- 11.Dong WQ, Bai B, Lin YP, Zeng QS (2007) Case control study of avascular necrosis of femoral head during SARS patients’ convalescence. Chinese J Postgraduates of Med 30:1–3Google Scholar
- 12.Gao HS, Wang SX, Gao X, Cao X, Hui WL, Li YM, Yang Z, Su B (2005) Nested case-control study of avascular necrosis of femoral head during SARS patients’convalescence. Acta Academiae Medicinae CPAPF 14:11–13Google Scholar
- 14.Han YK, Zhou XZ, Zeng Z et al (2005) Osteonecrosis in post-SARS patients: a clinical study. Chinese J Nosocomiol 15:481–484Google Scholar
- 15.Liu BL, Li ZR, Sun W, Zhao FC (2009) The relationship of the range and location of osteonecrosis of the femoral head with the dose of steroid in SARS patients. Chin J Orthop 29:554–557Google Scholar
- 17.Wang HY (2011) The investigation of the SARS patients with ANFH in Beijing Ditan Hospital. Taishan Medical Institute, Taian, pp 1–52Google Scholar
- 18.Wang ZQ, Liu TS, Wang JG (2006) The clinical research of the SARS patients diagnosed with femur head necrosis. Tianjin Med J 34:50–51Google Scholar
- 19.Xu J, Yu XZ (2004) A study on correlativity between glucocorticoids and femoral head necrosis in patients with severe acute respiratory syndrome. Chinese J Emerg Med 13:697–699Google Scholar
- 21.Cheng XG, Qu H, Liu W, Liu X, Cheng KB, Zhao T, Li XS, Liang W, Guo J (2005) The prevalence of osteonecrosis in severe acute respiratory syndrome patients: an MRI screening study. Chin J Radiol 39:791–797Google Scholar
- 22.Cheng XG, Qu H, Liu W, Sun J, Cheng KB, Feng SC, Li XS (2004) MRI screening on bone ischemia of hip and knee in recovered SARS patients. Chinese J Radiol 38:230–235Google Scholar
- 23.Chen WH, Zhang Q, Liu DB, Zhang HM, Zhang L, Gu LJ, Sun G, Zhao TJ, Zhou W (2004) Analysis of attacking characteristics and clinical significant about osteonecrosis of the femoral head secondary to SARS. China J Orthopaedics Traumatol 17:388–390Google Scholar
- 26.Wang Z, Liu T, Wang J (2007) The clinical research of the SARS patients diagnosed with Femur Head Necrosis. Orthopaedic new technology seminar for the police force, Tianjing, pp 190–192Google Scholar
- 27.Higgins J, Green S (2008) Cochrane Reviewers’ handbook 5.0.1 (updated September 2008). The Cochrane library. Wiley, ChichesterGoogle Scholar
- 32.Shibatani M, Fujioka M, Arai Y, Takahashi K, Ueshima K, Okamoto M, Yoshimura N, Hirota Y, Fukushima W, Kubo T (2008) Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head. Acta Orthop 79:631–636CrossRefPubMedGoogle Scholar